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The amino acid sequence of protein Z has been determined from sequence analysis performed on fragments 
obtained by chemical and enzymatic degradations. The polypeptide consists of a single chain containing 
396 amino acid residues (Mr 43 677). Comparison with the vitamin K-dependent plasma proteins reveals 
an extensive homology. The N-terminal part, containing 13 y-carboxyglutamic acid and one /?-hydroxyas- 
partic acid residue, is extensively homologous to and of similar length to the light chain of factor X. The 
remainder of protein Z is homologous to the serine proteases and of similar size to the heavy chain of factor 
Xa, but of the active site residues only aspartic acid-102 is present. Histidine-57 and serine-195 are replaced 
in protein Z by threonine and alanine, respectively. The physiological function of protein Z is still uncertain. 
y-Carboxyglumatic acid /_I-Hydroxyaspartic acid Haptoglobin Blood coagulation 
1. INTRODUCTION 
Protein Z is a single chain glycoprotein which 
has been purified from bovine [1,2], and human 
plasma [3]. It has a molecular mass of 50 kDa and 
contains 13 y-carboxyglutamic acid (Gla) residues 
within the amino-terminal 40 residues [4]. This 
amino-terminal sequence of protein Z is highly 
homologous with those of the well known vitamin 
K-dependent coagulation factors including protein 
C and protein S, but sufficiently different from 
these factors to identify protein Z as a distinct 
vitamin K-dependent protein. No functional assay 
is available for protein Z, and despite the strong 
similarity with the coagulation factors, antibodies 
raised against protein Z show no effect in standard 
clotting assays ([3]; unpublished). Furthermore, it 
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has not been possible to activate protein Z to a 
serine protease with proteolytic enzymes such as 
thrombin, factor Xa and trypsin (unpublished). 
Here we present he amino acid sequence of bovine 
protein Z, showing that protein Z is homologous 
to the serine proteases but due to mutation of 
essential amino acids, protein Z cannot function as 
a proteolytic enzyme. 
2. MATERIALS AND METHODS 
Bovine protein Z was purified by adsorption to 
barium citrate followed by ion-exchange 
chromatography as described [2]. A sample of pro- 
tein Z was also obtained from M.P. Esnouf. 
Trypsin, chymotrypsin and pepsin were pur- 
chased from Worthington, thermolysin and soy- 
bean trypsin inhibitor from Sigma and staphylo- 
coccal protease from Miles Laboratories. 
Sephacryl S-200 and Sephadex G-50, fine were 
from Pharmacia. 
The sequences of the smaller peptides were 
mainly determined manually, while longer se- 
quences were determined using a Beckman se- 
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quencer 890C. Detailed technical sequence together with the fragments used for elucidation of 
methods, including peptide separation by HPLC the structure. It contains 396 amino acid residues 
have been described [4,5]. ,&Hydroxyaspartic acid including 13 y-carboxyglutamic acids, one ,& 
was determined by amino acid analysis on a hydroxyaspartic acid, 3 asparagine-linked oligo- 
Beckman 121 MB analyzer as described by saccharide groups and one threonine-linked oligo- 
Drakenberg et al. [6], and a sample of P- saccharide group. The M, value of the peptide part 
hydroxyaspartic acid used as a standard was ob- of protein Z is 43 677, and the amino acid composi- 
tained from J. Stenflo. tion is shown in table 1. 
2.1. Degradation of protein Z 
Protein Z (41 mg) was degraded for 20 h with 
cyanogen bromide (80 mg in 70% formic acid) 
followed by reduction and carboxymethylation. 
The fragments were separated on a column of 
Sephacryl S-200 (2.5 x 80 cm) in 8 M urea, 50 mM 
ammonium acetate, pH 5.0. Reduced and carbox- 
ymethylated protein Z (150 mg) was digested with 
1.8 mg trypsin for 3 h at 37°C in 0.1 M am- 
monium bicarbonate, pH 8.3, and the reaction 
stopped by adding 2 mg soybean trypsin inhibitor. 
The resulting peptides were separated on a column 
of Sephadex G-50 (2.5 x 100 cm) in 0.1 M am- 
monium bicarbonate, pH 8.3, and further purified 
by high-voltage paper electrophoresis at pH 6.5 
and 2.1 or by HPLC. A similar digest using 
130 mg protein Z was performed with chymotryp- 
sin and the reaction stopped by adding 2 mg 
phenylmethanesulfonyl f uoride dissolved in 1 ml 
ethanol. The last digest of reduced and carbox- 
ymethylated protein Z (80 mg) was with 1 mg 
staphylococcal protease for 12 h at 37°C in 0.1 M 
ammonium bicarbonate. The peptides from this 
digest were also separated on a column of 
Sephadex G-50 (2.5 x 100 cm) in 0.1 M am- 
monium bicarbonate, pH 8.3. The smaller peptides 
were further purified by HPLC, while the larger 
peptides were subdigested with pepsin. Subdigests 
with thermolysin were performed in 50 mM 
pyridinium acetate, 10 mM CaClz, pH 6.5, at 37°C 
while the pepsin subdigest was in 5% formic acid. 
Thirty-three tryptic peptides were isolated and 
characterized corresponding to the entire sequence 
of protein Z except for residues 321-347. This 
stretch of the sequence is particularly rich in 
hydrophobic residues, and the peptide was pro- 
bably lost because of low solubility. No special ef- 
fort was taken to isolate this peptide as the se- 
quence was unambiguously deduced from the 
chymotryptic and staphylococcal protease pep- 
tides. Thirty-two chymotryptic peptides were 
isolated and characterized. Their composition ac- 
counts for 96% of the sequence. All the tryptic and 
chymotryptic peptides are indicated in fig. 1, but 
only 3 of the staphylococcal protease peptides are 
shown because only minimal evidence is presented. 
In the evidence for the amino acid sequence, the 
overlap between T14 and T15 is based on the 3 
residue chymotryptic peptide C18. This results in a 
single residue overlap, but it is most unlikely that 
there are unknown peptides located between T14 
and T15 as the homology with factor X and hap- 
toglobin is good in this region (fig.2). Also, the 
composition of peptide Sp4Pel supports this 
conclusion. 
3.1. Postsynthetic modifications 
3. RESULTS 
Thirteen y-carboxyglutamic acids have been 
found in protein Z in positions 7, 8, 11, 15, 17, 20, 
21,26,27, 30,33,36 and 40 as published elsewhere 
[4]. The positions of the Gla residues are the same 
as the 10 in prothrombin plus the two in factor X 
and IX and protein C in the clotting factors. Pro- 
tein Z has an extra Gla-1 1 which is unique for this 
protein. 
The amino acid sequence of bovine protein Z 
was determined from peptides obtained by diges- 
tion of reduced and carboxymethylated protein Z 
with trypsin, chymotrypsin or staphylococcal pro- 
tease. The amino-terminal sequences of the 
cyanogen bromide fragments were also deter- 
mined. The sequence of protein Z is shown in fig. 1 
One ,&hydroxyaspartic acid has been assigned to 
position 64 in protein Z. We have not been able to 
obtain full sequence vidence for the exact location 
of the ,&hydroxyaspartic acid mainly due to the 
carbohydrate group attached to the nearby 
Asn-59. As judged by amino acid analysis, the pep- 
tide C3Thl (residues 57-65) contained one fl- 
hydroxyaspartic acid. This peptide was purified by 
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Fig.1. Amino acid sequence of bovine protein Z. The figure summarizes the peptides used in deducing the sequence. 
Gla, y- ~r~oxyglutamic acid; CHU, carbohydrate; OH, hydroxy group attached to aspartic acid ~-hydroxy~parti~ 
acid); Tl-T33, fragments isolated from a tryptic digest; Cl-C32, chymotryptic peptides; CBl-CB3, cyanogen bromide 
peptides; Sp, staphylococcal protease peptides; C3Th1, thermolytic digest of peptide C3; Sp4Pe1, peptic peptide from 
Sp4. Sequence vidence for residues 1-42 has been published in [4]. 
RPLC after digestion af peptide C3 with ther- analysis of one ~-hydro~~pa~~c acid in peptide 
molysin but the yield obtained was too low for an C3Thl and in all the other pcptides containing 
amino acid sequence determination. In none of the position 64, the consistent absence of a Pth 
other sequence runs of this area was a clear Pth derivative in this position, and the high degree of 
derivative af ,&hydroxyaspartic acid seen. Never- homology with protein C [6], factor IX [9J and fac- 
theless, the unambiguous finding by amino acid tor X [9,I l], all of which contain one fl- 
335 
Volume 184, number 2 FEBS LETTERS May 1985 
Table 1 
Amino acid composition of bovine protein Z 
Sequence Amino acid 
analysis 
GYs 24 21 
Asp 18 _ 
Asn 9 - 
Asp-OH 1 - 
Asx - 30 
Thr 23 21 
Ser 18 22 
Glu 14 - 
Gin 15 - 
Gla 13 - 
Glx _ 46 
Pro 32 30 
Gly 43 38 
Ala 35 32 
Val 25 29 
Met 2 4 
Be 5 8 
Leu 38 36 
Tyr 9 10 
Phe 12 12 
LYS 6 11 
His 12 11 
Trp 8 7 
Arg 34 29 
Asp-OH, fl-hydroxyaspartic acid; Gla, y-carboxyglu- 
tamic acid. The amino acid analysis is taken from [2] 
hydroxyaspartic acid in the corresponding posi- 
tion, strongly indicate that a &hydroxyaspartic 
acid is located in position 64. The finding of one 
,&hydroxyaspartic acid is in agreement with the 
amino acid analysis results of Fernlund and 
Stenflo [12], who found 0.85 mol fl-hydroxyas- 
partic acid per mol protein in bovine protein Z. 
Three oligosaccharide groups containing gluco- 
samine were found attached to Asn-59, Asn-191 
and Asn-289 all obeying the Asn-X-Ser/Thr gly- 
cosylation rule. A fourth oligosaccharide group 
containing galactosamine was found attached to 
Thr-388 in agreement with the Thr/Ser-X-X-Pro 
glycosylation rule. An oligosaccharide is found in 
the position equivalent to Thr-388 in factor X. 
Direct sequence evidence was not found for 
Asn-59, but the position was deduced from the 
336 
consistent presence of Asx and carbohydrate in all 
amino acid analysis of peptides covering this area 
and in the absence of a Pth derivative during 
sequencing of the carbohydrate-containing step. 
4. DISCUSSION 
Protein Z is a single chain protein whose se- 
quence shows homology with the factor X-like 
coagulation factors. This is illustrated in fig.2, 
where protein Z is aligned with factor X and hap- 
toglobin. The Gla region consists of the amino- 
terminal 42 residues which are found in all the 
vitamin K-dependent coagulation factors. Then 
follows a region (residues 43-134) which shows 
45% identity with the light chain of factor X in- 
cluding a fl-hydroxyaspartic acid in position 64. A 
short stretch of amino acid residues leads to the 
part of protein Z which is homologous with the 
serine proteases. The latter region shows 23% 
identity with the heavy chain of factor X. This is 
only slightly less than the identity of haptoglobin 
to factor X (25%). It is clear that like haptoglobin 
protein Z cannot show any proteolytic activity 
because the residue that would correspond to the 
active serine (195 in chymotrypsin) is Ala-3 11 in 
protein Z and also the active site histidine (57 in 
chymotrypsin) is changed to a threonine (Thr- 184). 
As in haptoglobin, Asp-102 (chymotrypsin 
numbering) is however present in protein Z 
(Asp-221). 
Most serine proteases are activated by cleavage 
of a single peptide bond on the carboxy-terminal 
side of an arginine residue resulting in a new 
amino-terminal valine or isoleucine (Ile-16 in 
chymotrypsin). The arrow in fig.2 points at the ac- 
tivation bond in factor X. A similar activation of 
protein Z seems to be impossible as the area 
around the corresponding bond is quite different 
in protein Z compared to the serine proteases, and 
would not be a good substrate for an activating 
Arg-specific protease. 
The 17 ‘extra’ amino acid residues found in hap- 
toglobin are not seen in protein Z (inserted be- 
tween position 295 and 296 using protein Z 
numbers), but a carboxy-terminal tail similar to 
that found in factor X is present with the insertion 
of an extra 12 residues in protein Z. Also, the O- 
linked carbohydrate is present in a homologous 
position (Thr-388). 
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220) 230 
Fig.2. Sequence comparison of bovine protein Z (Zb) with bovine factor X (Xb) [7-91, human protein Z (Zh) [3] and 
human haptoglobin (Hh) [lo]. Boxed residues are identical to corresponding residues in protein Z. The star in the 
sequence of factor X indicates the omission of 50 residues of the activation peptide. The arrow points to the activation 
bond in factor X. The standard single-letter code is used except for 7, y-carboxyglutamic acid; ,f3, fl-hydroxyaspartic 
acid; X, unidentified residues presumed to be y-carboxyglutamic acid. 
All the half-cystines found in the light chain of 
factor X are also present in protein Z and of the 3 
disulfide loops common to most serine proteases 
(histidine 42-58, methionine 168- 182 and serine 
191-220, using chymotrypsin numbering) only the 
histidine and methionine loops are present in pro- 
tein Z. The two half-cystines forming the disulfide 
bond in the serine loop are probably replaced by 
Ala-307 and Pro-333 in protein Z. 
Four half-cystines in protein 2 (residues 13 1, 
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140, 141 and 233) have not been found in the other 
proteins, and are therefore likely to constitute two 
‘additional’ disulfide bridges. As two of these half- 
cystines are adjacent to each other in the sequence 
they cannot form a mutual disulfide bond and 
therefore either Cys-140 or Cys-141 must be bond- 
ed to Cys-131 and the other one to Cys-233. 
In protein Z Cys-241 is found in a position cor- 
responding to one of the half-cystines (Cys-122 in 
chymotrypsin) which form an inter-chain bridge 
common to all the two-chain serine proteases. This 
is in agreement with the number of half-cystines 
found in the area homologous with the light chain 
of factor X. 
This work shows that protein Z is a serine pro- 
tease homolog which on structural grounds should 
be unable to function as a serine protease. The 
physiological function of protein Z is still not 
known, but the homology with the other vitamin 
K-dependent plasma proteins indicates an affinity 
for the same surfaces and like haptoglobin it may 
serve as a binding protein. 
ACKNOWLEDGEMENTS 
We thank N. Axelsen, Statens Seruminstitut, 
Kerbenhavn, for raising the antibodies against pro- 
tein Z. This work was supported by the US Na- 
tional Heart, Lung and Blood Institute, National 
Institutes of Health, Bethesda, MD (grant 
HL 16238) and the Danish Science Research Coun- 
cil (grant 1 l-2301). 
REFERENCES 
HI 
PI 
t31 
141 
151 
161 
t71 
181 
191 
[lOI 
Ull 
WI 
Prowse, C.V. and Esnouf, M.P. (1977) Biochem. 
Sot. Trans. 5, 255-256. 
Petersen, T.E., Thagersen, H.C., Sottrup-Jensen, 
L., Magnusson, S. and Jornvall, H. (1980) FEBS 
Lett. 114, 278-282. 
Broze, G.J. and Miletich, J.P. (1984) J. Clin. 
Invest. 73, 933-938. 
Hojrup, P., Roepstorff, P. and Petersen, T.E. 
(1982) Eur. J. Biochem. 126, 343-348. 
Skorstensgaard, K., Thogersen, H.C., Vibe- 
Pedersen, K., Petersen, T.E. and Magnusson, S. 
(1982) Eur. J. Biochem. 128, 605-623. 
Drakenberg, T., Fernlund, P., Roepstorff, P. and 
Stenflo, J. (1983) Proc. Natl. Acad. Sci. USA 80, 
1802- 1806. 
Enfield, D.L., Ericsson, L.H., Walsh, K.A., 
Neurath, H. and Titani, K. (1975) Proc. Natl. 
Acad. Sci. USA 72, 16-19. 
Titani, K., Fujikawa, K., Enfield, D.L., Ericsson, 
L.H., Walsh, K.A. and Neurath, H. (1975) Proc. 
Natl. Acad. Sci. USA 72, 3082-3086. 
Sugo, T., Fernlund, P. and Stenflo, J. (1984) FEBS 
Lett. 165, 102-106. 
Kurosky, A., Barnett, D.R., Lee, T.-H., 
Touchstone, B., Hay, R.E., Arnott, M.S., 
Bowman, B.H. and Fitch, W.M. (1980) Proc. Natl. 
Acad. Sci. USA 77, 3388-3392. 
McMullen, B.A., Fujikawa, K., Kisiel, W., 
Sasagawa, T., Howald, W.N., Kwa, E.Y. and 
Weinstein, B. (1983) Biochemistry 22, 2875-2884. 
Fernlund, P. and Stenflo, J. (1983) J. Biol. Chem. 
258, 12509-12512. 
338 
